⌘K
Loading ticker…
Cytek Biosciences, Inc. Common Stock · Healthcare · Measuring & Control Equipment
As of 2026-06-26, Cytek Biosciences, Inc. Common Stock (CTKB) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.7%, relative volume 1.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
36 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CTKB is in a stage 1 base, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 6.6% / -0.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CTKB is held by 5 ETFs as of Mar 2026. Top owner: IJR at 0.03% weight, $29M notional. Top 3 carry $56M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJRiShares Core S&P Small-Cap ETF | 0.03% | $29M |
| VTIVanguard Total Stock Market ETF | 0.00% | $15M |
| IWMiShares Russell 2000 ETF | 0.02% | $13M |
| VXFVanguard Extended Market ETF | 0.01% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $506K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CTKB Jan avg: -5.21% median: -9.10% win: 25% σ: 17.70% n: 4 2022-04-12 → 2026-05-29 | CTKB Feb avg: -8.94% median: -11.61% win: 25% σ: 7.48% n: 4 2022-04-12 → 2026-05-29 | CTKB Mar avg: -9.20% median: -10.73% win: 0% σ: 4.60% n: 4 2022-04-12 → 2026-05-29 | CTKB Apr avg: 0.67% median: -7.48% win: 40% σ: 14.71% n: 5 2022-04-12 → 2026-05-29 | CTKB May avg: -13.80% median: -8.11% win: 20% σ: 14.37% n: 5 2022-04-12 → 2026-05-29 | CTKB Jun avg: 10.43% median: 9.93% win: 75% σ: 9.68% n: 4 2022-04-12 → 2026-05-29 (current) | CTKB Jul avg: 12.59% median: 12.59% win: 100% σ: 8.32% n: 4 2022-04-12 → 2026-05-29 | CTKB Aug avg: -5.91% median: -11.72% win: 25% σ: 14.21% n: 4 2022-04-12 → 2026-05-29 | CTKB Sep avg: -5.17% median: -9.83% win: 25% σ: 23.17% n: 4 2022-04-12 → 2026-05-29 | CTKB Oct avg: -4.16% median: -2.65% win: 50% σ: 16.25% n: 4 2022-04-12 → 2026-05-29 | CTKB Nov avg: 31.21% median: 38.46% win: 75% σ: 34.82% n: 4 2022-04-12 → 2026-05-29 | CTKB Dec avg: -0.15% median: -5.62% win: 25% σ: 22.60% n: 4 2022-04-12 → 2026-05-29 |